THIS VOLUNTARY REPORTING SYSTEM
MONITORS THE QUALITY OF DRUGS IN THE MARKETPLACE. THE SYSTEM HAS
RAPIDLY UNCOVERED HEALTH HAZARDS OR CIRCUMSTANCES WHICH MAY
INCREASE PATIENT/CONSUMER RISK. THIS MECHANISM UTILIZES THE
PROFESSIONALISM OF THE NATION'S PHARMACISTS. DQRS INFORMATION ALSO
PROVIDES FDA WITH TIMELY SURVEILLANCE DATA TO DIRECT FIELD
INSPECTIONAL OPERATIONS.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.